10/04/2026
Biomarkers, Advanced Therapies, and New Targets Drive Change in Parkinson’s Research
Parkinson’s disease is the second most common neurodegenerative disorder and affects more than 160,000 people in Spain, with an estimated prevalence of between 20,000 and 25,000 patients in Cataloni...